123 related articles for article (PubMed ID: 38360383)
1. Exploring the anti-ferroptosis mechanism of Kai-Xin-San against Alzheimer's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vivo and in vitro.
Yan C; Yang S; Shao S; Zu R; Lu H; Chen Y; Zhou Y; Ying X; Xiang S; Zhang P; Li Z; Yuan Y; Zhang Z; Wang P; Xie Z; Wang W; Ma H; Sun Y
J Ethnopharmacol; 2024 May; 326():117915. PubMed ID: 38360383
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
Wang K; Yang R; Chen TT; Qin MR; Wang P; Kong MW
Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082
[TBL] [Abstract][Full Text] [Related]
3. Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway.
Shan X; Tao W; Li J; Tao W; Li D; Zhou L; Yang X; Dong C; Huang S; Chu X; Zhang C
J Ethnopharmacol; 2024 Jul; 329():118145. PubMed ID: 38582153
[TBL] [Abstract][Full Text] [Related]
4. Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease.
Yi P; Zhang Z; Huang S; Huang J; Peng W; Yang J
Pharm Biol; 2020 Dec; 58(1):932-943. PubMed ID: 32956608
[TBL] [Abstract][Full Text] [Related]
5. Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice.
Jiao YN; Zhang JS; Qiao WJ; Tian SY; Wang YB; Wang CY; Zhang YH; Zhang Q; Li W; Min DY; Wang ZY
Mol Neurobiol; 2022 May; 59(5):3294-3309. PubMed ID: 35303280
[TBL] [Abstract][Full Text] [Related]
6. Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice.
Xu YM; Lu FM; Xu HC; Zhang J; Hei SY; Qiu YH; Cai YF; Zhang SJ; Zhao M
Rejuvenation Res; 2023 Jun; 26(3):105-115. PubMed ID: 37073462
[TBL] [Abstract][Full Text] [Related]
7. Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer's disease through SIRT3/NLRP3 pathway.
Su S; Chen G; Gao M; Zhong G; Zhang Z; Wei D; Luo X; Wang Q
Chin Med; 2023 Mar; 18(1):26. PubMed ID: 36918872
[TBL] [Abstract][Full Text] [Related]
8. Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease.
Luo Y; Li D; Liao Y; Cai C; Wu Q; Ke H; Liu X; Li H; Hong H; Xu Y; Wang Q; Fang J; Fang S
Front Pharmacol; 2020; 11():381. PubMed ID: 32317964
[TBL] [Abstract][Full Text] [Related]
9. Classic Famous Prescription Kai-Xin-San Ameliorates Alzheimer's Disease via the Wnt/β-Catenin Signaling Pathway.
Shan X; Lv S; Huang P; Zhang W; Jin C; Liu Y; Li Y; Jia Y; Chu X; Peng C; Zhang C
Mol Neurobiol; 2024 Apr; 61(4):2297-2312. PubMed ID: 37874481
[TBL] [Abstract][Full Text] [Related]
10. Kai-xin-san improves cognitive impairment in D-gal and Aβ
Wang H; Zhou L; Zheng Q; Song Y; Huang W; Yang L; Xiong Y; Cai Z; Chen Y; Yuan J
J Ethnopharmacol; 2024 Jul; 329():118161. PubMed ID: 38599474
[TBL] [Abstract][Full Text] [Related]
11. Classic Prescription, Kai-Xin-San, Ameliorates Alzheimer's Disease as an Effective Multitarget Treatment: From Neurotransmitter to Protein Signaling Pathway.
Guo S; Wang J; Xu H; Rong W; Gao C; Yuan Z; Xie F; Bi K; Zhang Z; Li Q
Oxid Med Cell Longev; 2019; 2019():9096409. PubMed ID: 31354916
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
[TBL] [Abstract][Full Text] [Related]
13. Study on the chemical constituents and mechanism of Kai-Xin-San based on UPLC-Q-Exactive MS and network pharmacology.
Shang B; Jia S; Zhang T; Gao F; Lu M; Chen K; Jiao J; Dai Z; Zeng Q; Xu B; Lei H
J Ethnopharmacol; 2024 Mar; 322():117652. PubMed ID: 38151178
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like effect of the extracted of Kai Xin San, a traditional Chinese herbal prescription, is explained by modulation of the central monoaminergic neurotransmitter system in mouse.
Zhou XJ; Liu M; Yan JJ; Cao Y; Liu P
J Ethnopharmacol; 2012 Jan; 139(2):422-8. PubMed ID: 22138350
[TBL] [Abstract][Full Text] [Related]
15. Chinese traditional formula Kaixin San suppressed ferroptosis of hippocampal neurons and cardiomyocytes in mice with paradoxical sleep deprivation.
Cao Y; Li M; Gu L; Zhao X; Zhou A; Miao Y; Wu Y; Ke Z; Hu R; Wang Z; Wu X
J Ethnopharmacol; 2023 Mar; 304():116034. PubMed ID: 36529245
[TBL] [Abstract][Full Text] [Related]
16. Network pharmacology-based analysis of Jin-Si-Wei on the treatment of Alzheimer's disease.
Zhi J; Yin L; Zhang Z; Lv Y; Wu F; Yang Y; Zhang E; Li H; Lu N; Zhou M; Hu Q
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117291. PubMed ID: 37925002
[TBL] [Abstract][Full Text] [Related]
17. Rapid discovery of quality-markers from Kaixin San using chinmedomics analysis approach.
Wang XJ; Zhang AH; Kong L; Yu JB; Gao HL; Liu ZD; Sun H
Phytomedicine; 2019 Feb; 54():371-381. PubMed ID: 30322673
[TBL] [Abstract][Full Text] [Related]
18. High-throughput lipidomics analysis to discover lipid biomarkers and profiles as potential targets for evaluating efficacy of Kai-Xin-San against APP/PS1 transgenic mice based on UPLC-Q/TOF-MS.
Zhang AH; Ma ZM; Kong L; Gao HL; Sun H; Wang XQ; Yu JB; Han Y; Yan GL; Wang XJ
Biomed Chromatogr; 2020 Feb; 34(2):e4724. PubMed ID: 31755117
[TBL] [Abstract][Full Text] [Related]
19. SuanZaoRen decoction alleviates neuronal loss, synaptic damage and ferroptosis of AD via activating DJ-1/Nrf2 signaling pathway.
Long Q; Li T; Zhu Q; He L; Zhao B
J Ethnopharmacol; 2024 Apr; 323():117679. PubMed ID: 38160863
[TBL] [Abstract][Full Text] [Related]
20. Active components, derived from Kai-xin-san, a herbal formula, increase the expressions of neurotrophic factor NGF and BDNF on mouse astrocyte primary cultures via cAMP-dependent signaling pathway.
Cao C; Xiao J; Liu M; Ge Z; Huang R; Qi M; Zhu H; Zhu Y; Duan JA
J Ethnopharmacol; 2018 Oct; 224():554-562. PubMed ID: 29890314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
